In preclinical models, suramin (polysulfonated naphthylurea) has been shown to have a strong inhibitory effect on heparanase activity in B16 melanoma cells and their subsequent invasiveness in reconstructed basal membranes [83]. Here, HPSE is linked to melanoma.